文献速递免疫规划

中国广州儿童以脑膜炎球菌多糖结合疫苗替代脑膜炎球菌多糖疫苗的免疫原性研究

Immunogenicity of meningococcal polysaccharide conjugate vaccine as a replacement for meningococcal polysaccharide vaccine in children in Guangzhou, China.
PubMed 文献 · Vaccine · 2022-01-31

该观察性研究评估了广州3岁组131名和6岁组47名儿童以两剂MPCV-AC替代MPSV-A后的抗体持久性。3岁组在首剂MPSV加强后1个月,Men A和Men C的血清保护率和GMT显著升高。替代接种程序在幼儿中显示良好免疫原性,并与MPSV加强免疫显示良好序贯免疫原性。

要点

  • 3岁组在首剂MPSV加强后1个月,Men A和Men C的血清保护率和GMT显著升高。
  • 3岁组首剂MPSV加强前所有免疫指标显著低于6岁组第二剂MPSV加强前。
  • 3岁组首剂MPSV加强后1个月与6岁组第二剂MPSV加强前多数免疫指标无显著差异。

核心结论

  • 替代脑膜炎球菌免疫程序在幼儿中显示良好免疫原性,并与MPSV加强免疫显示良好序贯免疫原性。

研究设计与样本

  • 观察性研究,纳入2017年3月至2018年3月在中国广州自愿接种两剂MPCV-AC替代MPSV-A的儿童,3岁组131人,6岁组47人。

主要发现

  • 3岁组在首剂MPSV加强后1个月,Men A和Men C的血清保护率和GMT值显著升高。
  • 3岁组首剂MPSV加强前所有免疫指标显著低于6岁组第二剂MPSV加强前。
  • 3岁组首剂MPSV加强后1个月与6岁组第二剂MPSV加强前多数免疫指标无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

To assess the durability of antibody persistence after substitution of the MPCV vaccine for the MPSV-A vaccine in children, an observational study was conducted in children who voluntarily received two doses of MPCV-AC instead of MPSV-A between March 2017 and March 2018 in Guangzhou, China. In total, 131 and 47 participants were enrolled in the 3-year-old and 6-year-old groups, respectively. In the 3-year-old group, the seroprotection rate and GMT values for Men A and Men C were raised significantly after 1-month post- dose 1 MPSV booster vaccination. All immune indicators were significantly lower in pre- dose 1 MPSV booster vaccination in the 3-year-old group than after pre- dose 2 MPSV booster vaccination in the 6-year-old group. While no significant differences were found in most immune indicators between the 1-month post- dose 1 MPSV booster vaccination in the 3-year-old group and pre- dose 2 MPSV booster vaccination in 6-year-old group. The substitute meningococcal immunization schedule showed a good immunogenicity in young children, and good sequential immunogenicity with MPSV booster immunization.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. He Q, Xiao J, Liu M, et al. Immunogenicity of meningococcal polysaccharide conjugate vaccine as a replacement for meningococcal polysaccharide vaccine in children in Guangzhou, China. Vaccine. 2022. PMID: 35094869. doi:10.1016/j.vaccine.2021.09.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。